A genetically engineered enzyme raises a new question for organic production rules

OMRI announcement: 29 July 2026 · Published here:

Short version

Full version →

On 29 July 2026, OMRI announced that it would temporarily stop accepting new review applications for bacteriophage sanitizers marketed for organic handling when their production uses an enzyme derived from genetic engineering. The issue concerns a particular processing aid, not bacteriophages in general.

According to OMRI, the enzyme is separated from the bacteriophages and does not change their characteristics. Nevertheless, the review panel could not determine how the existing GMO Excluded Methods guide applies to this case. OMRI described the question as “beyond resolution” under current guidance and initiated a review of that guide.

Suppliers of listed bacteriophage products will be contacted as part of limited re-reviews. The announcement is neither a USDA decision nor a general change in legislation. It describes how OMRI is temporarily handling its own applications and listings while examining an unresolved interpretative issue.

The case highlights the importance of the production process and of aids that may not be present in the final product. OMRI listing does not prove efficacy and does not imply approval for use in Greece or the EU.

Full version

Short version ↑

OMRI has temporarily stopped accepting new applications for certain bacteriophage sanitizers produced using a genetically engineered enzyme. According to its announcement, the enzyme is removed from the bacteriophages and does not change their properties; the uncertainty concerns the application of OMRI's GMO guide.

What is the case about?

On 29 July 2026, the Organic Materials Review Institute (OMRI) announced that its review process could not determine whether to accept a bacteriophage sanitizer produced with the aid of a genetically modified enzyme. The sanitizer is intended for handling certified organic products.

OMRI says that the enzyme is used during production, is separated from the bacteriophage and does not alter any characteristic of the final phage. The question is therefore not whether the phage itself has been genetically modified, but how to treat a genetically engineered processing material that does not remain in the finished product.

OMRI reports that it examined the matter for nine months with its Processing Review Panel, Advisory Council and members of the ACA Materials Working Group. Because the existing Excluded Methods (GMO) Determination Guide did not clearly answer this particular case, OMRI called it “beyond resolution” under the present guidance.

OMRI's temporary decision

Until the issue is resolved, OMRI will not accept review applications for bacteriophage sanitizers marketed as handling materials that are manufactured with a genetically engineered enzyme processing aid. Suppliers of already OMRI-listed handling products that are or contain bacteriophages will be contacted during limited re-reviews.

At the same time, OMRI is beginning a review of its GMO guide, used since 2007 to determine whether an input is regarded as a genetically modified organism or a product of one. The announcement offers neither a final new interpretation nor a timetable for completing the review.

What the announcement does not mean

OMRI's temporary policy is not a USDA regulation or a National Organic Program decision covering all organic operations. US federal organic rules prohibit certain genetic engineering practices, but the assessment of processing aids and their residues depends on the applicable standard and the relevant certification authority. OMRI itself presents this as a pending question of interpretation in its own review process.

Nor is this a blanket rejection of bacteriophages as a category. The announcement concerns applications for a particular handling sanitizer made with a specific process involving a genetically engineered enzyme. It proves neither the product's effectiveness nor its safety; it describes only OMRI's review and temporary administrative measure.

The practical lesson is that input assessment may require information beyond the label and the identity of the final microorganism: which processing aids were used, at what stage, whether they were removed or remain, and what standard the certifier applies. OMRI listing relates to OMRI's review framework and is not, on its own, authorisation for use in Greece or the European Union.

Sources

  1. OMRI, GMO Guide to be Reviewed with New “Beyond Resolution” Issue, 29 July 2026.
  2. OMRI, Excluded Methods (GMO) Determination Guide.
  3. USDA Agricultural Marketing Service, Organic Regulations.
  4. USDA National Organic Program, 7 CFR Part 205.